Heart Valve Involvement (Mitral Valve Regurgitation) Caused by Libman–Sacks Endocarditis in Systemic Lupus Erythematosus : A Case Report and Review of the Literature
Downloads
Libman–Sacks (LS) endocarditis is one of the most common cardiac manifestations of both systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS).
We report a case of mitral valve replacement for mitral regurgitation (MR) caused by Libman-Sacks endocarditis in young patient with systemic lupus erythematosus (SLE).
In conclusion, Although typically mild and asymptomatic, the disease can lead to serious complications, including superimposed bacterial endocarditis, thromboembolic events, and severe valvular regurgitation and/or stenosis requiring surgery.
Galve E, Candell-Riera J, Pigrau C, et al. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med. 1988;319:817-823
Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701–7.
Ziporen L, Goldberg I, Arad M, et al. Libman-sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart
valves. Lupus. 1996;5(3):196–205.
Feigenbaum HAW, Ryan T. Feigenbaum’s Echocardiography. Philadelphia:
Lippincott Williams and Wilkins; 2005
Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement
(libman-sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93(8):1579–87
Doherty NE, Siegel RJ: Cardiovascular manifestations of systemic lupus
eryhematosus. Am Heart J 1985, 110:1257-65.
Ansari A, Larson PH, Bates HD: Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis 1985, 27:421-34.
Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM: Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 2007, 120:636-42.
Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH: Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992, 20:1127-34.
Roldan CA, Shively BK, Crawford MH: An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus.N Engl J Med 1996, 335:1424-30.
Hughes GR, Harris NN, Gharavi AE: The anticardiolipin syndrome. J Rheumatol 1986, 13:486-9
Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R,Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA: International consensus statement on preliminary classification criteria for definite Bouma et al. Journal of Cardiothoracic Surgery 2010, 5:13 http://www.cardiothoracicsurgery.org/content/5/1/13 Page 11 of 13 antiphospholipid syndrome: report of an international workshop. Artritis Rheum 1999, 42:1309-11.
Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, Vázquez JJ, Paré C, Ingelmo M, Oliver J, Hughes GR: Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus.Lancet 1990, 335:1541-4.
Cervera R, Khamashta MA, Font J, Reyes PA, Vianna JL, López-Soto A,
Amigo MC, Asherson RA, Azqueta M, Paré C, Vargas J, Romero A, Ingelmo M Hughes GRV: High prevalence of significant heart valve lesions in patients with the “primary” antiphospholipid syndrome. Lupus 1991, 1:43-7
Stevens MB. Systemic lupus erythematosus and the cardiovascular system: the heart. In: Lahita RG, ed. Systemic lupus erythematosus. New
York: Churchill Livingstone; 1992:707–717.
Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc. 1999;74:275–284
Maja Hojnik, Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome,15 Apr 1996
https://doi.org/10.1161/01.CIR.93.8.1579Circulation. 1996;93:1579–158, AHA scientific journal
Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-DelCastillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of
cardiac valvular disease in systemic lupus erythematosus. N Engl J Med. 1988;319:817–823.
Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. NEngl J Med. 1996;335:1424–1430
Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120:636–642.
Bai et al. Journal of Cardiothoracic Surgery (2015) 10:93 DOI 10.1186/s13019-015-0302-1 Diagnosis and surgical treatment for isolated tricuspid libman-sacks endocarditis: a rare case report and literatures review
Bouma et al. Journal of Cardiothoracic Surgery 2010, 5:13
http://www.cardiothoracicsurgery.org/content/5/1/13 Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature
Moyssakis , Libman-Sacks Endocarditis in Systemic Lupus Erythematosus: Prevalence, Associations, and Evolution Ioannis , The American Journal of Medicine (2007) 120, 636-642, ELSEVIER
Elizabeth S ,Clinical Practice Clinical Vignettes ,Mitral Valve Perforation in Libman–Sacks Endocarditis: A Heart-Wrenching Case of Lupus ,J Gen Intern Med 31(8):964–9 DOI: 10.1007/s11606-016-3640-3 © Society of General Internal Medicine 2016
Copyright (c) 2024 G. Ziani, N. Belharty, M. Cherti
This work is licensed under a Creative Commons Attribution 4.0 International License.
All Content should be original and unpublished.
